ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/18/2025
Back to search
Official data from USPTO
LENTI-D
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
12/20/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
03/15/2018
Registration date
11/13/2018
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/07/2025
Last transaction
12/20/2025
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
US
Examiner
KUYKENDALL,LYNDSEY
Current location
Historical data usage
Holders and representatives
Holders
Genetix Biotherapeutics, Inc.
bluebird bio, Inc.
bluebird bio (UK) Ltd.
Representatives
bluebird bio, Inc.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of genetic diseases
Publications
History of USPTO decisions and trademark events.
39 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/13/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
02/07/2025
71AG
REGISTERED-SEC.71 ACCEPTED
02/07/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12/30/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/13/2024
ES71
TEAS SECTION 71 RECEIVED
05/29/2024
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
12/23/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/13/2023
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/26/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/15/2019
NREP
NEW REPRESENTATIVE AT IB RECEIVED
10/18/2019
CHLD
CHANGE OF OWNER RECEIVED FROM IB
06/13/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/16/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/22/2019
FIMP
FINAL DISPOSITION PROCESSED
02/22/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/13/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
11/13/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/28/2018
PUBO
PUBLISHED FOR OPPOSITION
08/28/2018
GPNX
NOTIFICATION PROCESSED BY IB
08/24/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/08/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/08/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/08/2018
RFNT
REFUSAL PROCESSED BY IB
07/27/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/19/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/19/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/18/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/18/2018
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/18/2018
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/18/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/11/2018
RFRR
REFUSAL PROCESSED BY MPU
07/11/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/27/2018
CNRT
NON-FINAL ACTION WRITTEN
06/26/2018
DOCK
ASSIGNED TO EXAMINER
06/25/2018
MAFR
APPLICATION FILING RECEIPT MAILED
05/22/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/18/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/17/2018
Continuous trademark protection
Get notified about every new filing that threatens LENTI-D or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.